Brave Asset Management Inc Abbott Laboratories Transaction History

Brave Asset Management Inc

$368 Million
Q2 2025

A detailed history of Brave Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Brave Asset Management Inc holds 5,694 shares of ABT stock, worth $766,355. This represents 0.21% of its overall portfolio holdings.

Number of Shares

5,694

Previous 5,594 1.79%

Holding current value

$766,355

Previous $742,000 4.31%

% of portfolio

0.21%

Previous 0.23%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$123.95 - $138.08 $12,395 - $13,808	100 Added 1.79%	5,694 $774,000
Q4 2024 Jan 14, 2025	SELL	$111.93 - $119.39 $29,997 - $31,996	-268 Reduced 4.57%	5,594 $632,000
Q3 2024 Oct 10, 2024	SELL	$100.07 - $118.13 $30,020 - $35,439	-300 Reduced 4.87%	5,862 $668,000
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $10,073 - $11,244	-100 Reduced 1.6%	6,162 $640,000
Q1 2024 Apr 29, 2024	BUY	$109.52 - $120.96 $24,313 - $26,853	222 Added 3.68%	6,262 $711,000
Q4 2023 Jan 18, 2024	SELL	$90.19 - $110.4 $4,870 - $5,961	-54 Reduced 0.89%	6,040 $664,000
Q3 2023 Oct 13, 2023	SELL	$95.53 - $114.62 $16,717 - $20,058	-175 Reduced 2.79%	6,094 $590,000
Q1 2023 Apr 12, 2023	BUY	$96.86 - $114.01 $9,686 - $11,401	100 Added 1.62%	6,269 $634,000
Q1 2022 Apr 22, 2022	SELL	$114.02 - $139.04 $5,701 - $6,952	-50 Reduced 0.8%	6,169 $730,000
Q4 2021 Jan 21, 2022	SELL	$115.53 - $141.46 $5,660 - $6,931	-49 Reduced 0.78%	6,219 $875,000
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $11,549 - $12,776	99 Added 1.6%	6,268 $740,000
Q2 2021 Jul 27, 2021	SELL	$105.79 - $124.53 $30,150 - $35,491	-285 Reduced 4.42%	6,169 $715,000
Q1 2021 Apr 26, 2021	BUY	$108.84 - $128.23 $702,453 - $827,596	6,454 New	6,454 $773,000
Q4 2020 Jan 27, 2021	SELL	$105.0 - $114.42 $310,170 - $337,996	-2,954 Closed	0 $0
Q1 2020 Apr 16, 2020	BUY	$62.82 - $91.86 $19,097 - $27,925	304 Added 11.47%	2,954 $233,000
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $7,851 - $8,740	-100 Reduced 3.64%	2,650 $230,000
Q2 2019 Aug 05, 2019	BUY	$72.88 - $85.0 $7,288 - $8,500	100 Added 3.77%	2,750 $231,000
Q1 2019 May 03, 2019	BUY	$66.22 - $80.06 $175,483 - $212,159	2,650 New	2,650 $212,000

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.

Account

Brave Asset Management Inc Abbott Laboratories Transaction History